Moors & Cabot’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Sell
10,201
-268
-3% -$5.28K 0.01% 861
2026
Q1
$186K Buy
+10,469
New +$198K 0.01% 870
2021
Q4
Sell
-8,262
Closed -$210K 934
2021
Q3
$210K Sell
8,262
-78
-0.9% -$2.05K 0.01% 739
2021
Q2
$215K Sell
8,340
-265
-3% -$6.53K 0.02% 707
2021
Q1
$210K Buy
+8,605
New +$210K 0.02% 671

Other funds holding HQH

Moors & Cabot's HQH Position: Q2 2026 in Review

Moors & Cabot reduced its abrdn Healthcare Investors (HQH) stake by 2.6% in Q2 2026, selling an estimated $5.28K and leaving 10,201 shares worth $224K. The position accounts for 0.01% of the portfolio, ranked #861.

Moors & Cabot first reported a position in HQH in Q1 2021 and has held it in 5 quarters since. 126 funds tracked by Wall St. Rank hold HQH as of Q2 2026.

  • Moors & Cabot held 10,201 shares of abrdn Healthcare Investors worth $224K as of Q2 2026.
  • Moors & Cabot sold 268 abrdn Healthcare Investors shares in Q2 2026, an estimated $5.28K.
  • abrdn Healthcare Investors made up 0.01% of Moors & Cabot's portfolio in Q2 2026, its #861 holding.
  • Moors & Cabot first reported a position in abrdn Healthcare Investors in Q1 2021 and has held it in 5 quarters since.
  • 126 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.